Teva Pharmaceutical Industries - News and PR - - Search Tevapharm: - - Press Release Teva Announces Approval of Pergolide Mesylate Tablets Jerusalem, Israel, November 27, 2002 - Teva Pharmaceutical Industries Ltd.Pergolide Mesylate Tablets.Pergolide Mesylate ...
Paragraph IV Patent Certifications - DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
http://www.fda.gov/cder/orange/appendix_a.txt SODIUM, AMINOSALICYLATE SODIUM PACERONE, AMIODARONE HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAGITANE, CYCRIMINE HYDROCHLORIDE PAMELOR, NORTRIPTYLINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PAMINE FORTE, METHSCOPOLAMINE BROMIDE PAMINE, METHSCOPOLAMINE BROMIDE PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PANCURONIUM, PANCURONIUM BROMIDE PANDEL, HYDROCORTISONE PROBUTATE...
First-Time Generics - November 2002 Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search First-Time Generics - November 2002 - Generic Drug Name Generic Manufacturer Brand Name Product Approval Date 1 OMEPRAZOLE DELAYED-RELEASE CAPSULES 10 MG, AND 20 MG KREMERS URBAN DEVELOPMENT COMPANY PRILOSEC DELAYED-RELEASE CAPSULES 11/1/02 2 AMCINONIDE LOTION 0.1% ALTANA INC
author: OGD
Prescription and OTC Drug Product List 11/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;5MG N40478 001 NOV 08, 2002 NOV NEWA -A- AA 500MG;10MG N40473 001 NOV 06, 2002 NOV NEWA -A- AA 500MG;5MG N40477 001 NOV 06, 2002 NOV NEWA AMCINONIDE LOTION; TOPICAL -A- AMCINONIDE -A- AB ALTANA 0.1% N76329 001 NOV 06, 2002 NOV NEWA CYCLOCORT -D- + FUJISAWA...
RLD_LABELING_APPROVED_OCT_1999 Reference Listed Drug Labeling Approved in October 1999 Some of the product names below contain links to the approved labeling or the supplemental approval letter describing the specific changes.- Click on the product name to view the approved labeling changes in Adobe Acrobat format
News & PR - TEVA Pharmaceutical Industries Ltd TEVA ANNOUNCES APPROVAL OF PERGOLIDE MESYLATE TABLETS Jerusalem, Israel, November 27, 2002 - Teva Pharmaceutical Industries LtdPergolide Mesylate TabletsPergolide Mesylate TabletsPergolide Mesylate ...
FDA Drug Approvals List October 1999 Application #: 020156 Efficacy Supplement#: 022 Type: SE2 to Original New Drug Application Approval Date: 28-OCT-99 Trade Name: VIDEX Dosage Form: POWDER, FOR RECONSTITUTION Applicant: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE Active Ingredient(s): DIDANOSINE OTC/RX Status: RX Efficacy Claim:Provides for a new strength as well as allowing a change in dosing interval...
AMARIN CORPORATION ANNOUNCES SETTLEMENT OF PATENT LITIGATION WITH IVAX CORPORATION - Amarin Home Site Map Contact Us Graphics Version Printer Version Main Navigation ABOUT US COMPANY PROFILE Recent 2007 2006 2005 2004 2003 2002 2001 2000 STRATEGY Recent 2007 2006 2005 2004 2003 2002 2001 2000 MANAGEMENT TEAM Recent 2007 2006 2005 2004 2003 2002 2001 2000 BOARD OF DIRECTORS Recent 2007 2006 2005 2004 2003 2002 2001 2000 SCIENTIFIC ADVISORY BOARD Recent 2007 2006 2005 2004...
author: Webtrade Ltd. - http://www.webtrade.ie
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, OCUFEN to PYRIDIUM Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS OCUFEN to PYRIDIUM Trade Name Generic OCUFEN Flurbiprofen OCUPRESS Carteolol OMNIPEN Ampicillin ONCOVIN Vincristine OPHTHAINE Proparacaine OPHTHETIC Proparacaine ORETIC Hydrochlorothiazide ORETON Methyltestosterone ORINASE Tolbutamide ORUDIS Ketoprofen ORUVAIL Ketoprofen OXANDRIN Oxandrolone...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Paclitaxel to Rosiglitazone Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Paclitaxel to Rosiglitazone Generic Trade Name Paclitaxel TAXOL Pamidronate AREDIA Pancrelipase PANCREASE, VIOKASE Pancuronium PAVULON Papaverine PAVABID Paramethadione PARADIONE Paramethasone HALDRONE Pargyline EUTONYL Paromomycin HUMATIN Paroxetine PAXIL Penbutolol LEVATOL Penciclovir DENAVIR...
FORM 20-F page 10
author: FBOL Reception
Specificity Table TOX.xls Tested (ng/ ml) Paral Paraldehyde Sedative 1,000,000 Paramorphine Thebaine Opiate 100,000 OPI 24,000 para- Nitrophenol para- Nitrophenol Dye 100,000 Paraplatin Carboplatin Antineoplastic 100,000 Paredrine Amphetamine analog( Hydroxyamphetamine, p-) Amphetamine analog 200,000 AMP 20,000 Parlodel Bromoergocryptine, 2- a- Antiparkinsonian 100,000 Parnate Tranylcypromine Antidepressant...
author: Biosite Incorporated
Specificity Table TOX.xls page 20
author: Biosite Incorporated
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, OCUFEN to PYRIDIUM Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS OCUFEN to PYRIDIUM Trade Name Generic OCUFEN Flurbiprofen OCUPRESS Carteolol OMNIPEN Ampicillin ONCOVIN Vincristine OPHTHAINE Proparacaine OPHTHETIC Proparacaine ORETIC Hydrochlorothiazide ORETON Methyltestosterone ORINASE Tolbutamide ORUDIS Ketoprofen ORUVAIL Ketoprofen OXANDRIN Oxandrolone...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Paclitaxel to Rosiglitazone Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Paclitaxel to Rosiglitazone Generic Trade Name Paclitaxel TAXOL Pamidronate AREDIA Pancrelipase PANCREASE, VIOKASE Pancuronium PAVULON Papaverine PAVABID Paramethadione PARADIONE Paramethasone HALDRONE Pargyline EUTONYL Paromomycin HUMATIN Paroxetine PAXIL Penbutolol LEVATOL Penciclovir DENAVIR...
During the postmarketing surveillance for Permax, a small number of individuals have been identified as developing cardiac ... April 14, 2003 Dear Health Care Professional, This letter is being sent out following discussions with Health Canada regarding the use of PERMAX ® (pergolide mesylate) for the treatment of Parkinson's DiseasePERMAX was first launched in the US in 1989, a very limited number of cases have been reportedPergolide should be used with caution in...
author: Bernie Chiasson
During the postmarketing surveillance for Permax, a small number of individuals have been identified as developing cardiac ... page 1
author: Bernie Chiasson
http://www.adis.com/files/newsletters/REA/RXCOV940.PDF 3 Palivizumab prophylaxis safe for second RSV season 5 Spironolactone in heart failure 4 Treatment- related lung disorders occur after 5 years 3 Adverse Reaction Case Reports Abciximab: pulmonary haemorrhage [S] 6 Alteplase: increased menstrual bleeding [ ] 6 Apronalide/ ethenzamide: fixed drug eruption [ ] 6 Carbamazepine: bronchiolitis obliterans organising pneumonia [S] 7...
Draxis Pharmaceutica - Parkinson's Disease - - The majority of patients with Parkinson's Disease (PD) live out their normal life spansPermax Eldepryl Treatment for PD in the Draxis Pipeline Elan Pharmaceuticals www...
Teva Pharmaceutical Industries - News and PR - - Search Tevapharm: - - Press Releases Teva Announces Tentative Approval of Alendronate Sodium Tablets Jerusalem, Israel, December 30, 2002 Teva Announces the Grant of Summary Judgement for Mirtazapine Tablets, Generic Version of Remeron Jerusalem, Israel, December 18, 2002 Teva Shares Now Trading Ex-dividend Jerusalem, Israel, December 6, 2002 Teva Announces Approval of...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt 67480 AS MFG IN DENVER, PA" 15013 24-Aug-00 SOCHINAZ SA "PERGOLIDE MESYLATE AS MFG IN VIONNAZ, SWITZERLAND" 15014 02-Oct-00 INSTITUTE OF DRUG TECHNOLOGY AUSTRALIA LTD "MINOCYCLINE HYDROCHLORIDE USP AS MFG IN VICTORIA, AUSTRALIA" 15017 17-Aug-00 EVERLIGHT CHEMICAL IND CORP "MISOPROSTOL AS MFG IN TAOYUAN HSIEN, TAIWAN" 15021 12-Sep-00 ALPHARMA APS "TOBRAMYCIN SULPHATE, NON...
ANDA Approvals - September 2003 - FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Approvals - September 2003 - ANDA Number Generic Drug Name Applicant Approval Date 1 76-220 OFLOXACIN TABLETS 200 MG, 300 MG, AND 400 MG - RANBAXY LABORATORIES LIMITED 9/2/2003- 2 76-093 OFLOXACIN TABLETS 200 MG, 300 MG, AND 400 MG - PAR PHARMACEUTICAL, INC
